Snapshot from Jul 19, 2026 at 14:14 UTC. For live data and tracking: View Live
Events / Business / Modular Medical Launches Pivot Insulin Pump
Business product launch

Modular Medical Launches Pivot Insulin Pump

Analysis based on 27 articles · First reported Jun 04, 2026 · Last updated Jun 30, 2026

Sentiment
70
Attention
4
Articles
27
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The commercial launch and initial patient use of Modular Medical's Pivot tubeless insulin patch pump are expected to positively impact Modular Medical's stock price and market valuation. This event signifies the company's transition to a revenue-generating business, potentially attracting more investors to the medical device sector, particularly those focused on diabetes technology. The success of Pivot could also influence the competitive landscape for insulin delivery systems.

medical devices healthcare
Event Summary

Modular Medical has achieved a significant milestone by commercially launching its Pivot tubeless insulin patch pump and seeing the first patients actively use the device. This marks the company's transition from a development-stage to a commercial-stage medical device company. The Pivot pump, which received United States — Food and Drug Administration clearance in April 2026, is designed to simplify insulin pump therapy for adults with diabetes who currently rely on daily injections and have faced barriers with traditional systems. Modular Medical has begun shipping starter kits to endocrinology practices and is collecting real-world utilization data and user feedback to support broader adoption. The company aims to expand its offerings across select metropolitan markets by late 2026, targeting a multi-billion dollar market opportunity.

Key Actions
100 Modular Medical launched commercially
90 Modular Medical received clearance United States — Food and Drug Administration
70 Modular Medical launched website
70 Modular Medical began collecting data
Entities Involved
priv
Modular Medical
Modular Medical has successfully transitioned from a development-stage company to a commercial-stage medical device company with the launch and initial patient use of its Pivot tubeless insulin patch pump. This event is a significant milestone for the company, validating its vision and opening up a multi-billion dollar market opportunity.
Importance 100.0 Sentiment 75.0
per
Jeb Besser
Jeb Besser, the CEO of Modular Medical, has been instrumental in leading the company through the commercialization of the Pivot pump and has expressed optimism about its market potential.
Importance 70.0 Sentiment 60.0
govactor
United States — Food and Drug Administration
The United States — Food and Drug Administration granted 510(k) clearance for Modular Medical's Pivot tubeless insulin patch pump in April 2026, which paved the way for the commercial rollout of the device.
Importance 60.0 Sentiment 0.0
per
Paul DiPerna
Paul DiPerna founded Modular Medical and previously founded Tandem Diabetes, inventing its t:slim insulin pump, demonstrating his expertise in the field.
Importance 30.0 Sentiment 50.0
cnt
United States
The United States is the primary market for the commercial launch of Modular Medical's Pivot tubeless insulin patch pump, with plans for expansion across select metropolitan markets.
Importance 20.0 Sentiment 0.0
stock
Tandem Diabetes Care
Tandem Diabetes Care was founded by Paul DiPerna, who later founded Modular Medical, highlighting a lineage of innovation in insulin delivery technology.
Importance 10.0 Sentiment 0.0
Relationships
United States — Food and Drug Administration related ↔ United States
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.